Forma Therapeutics Holdings (FMTX) Misses Q2 EPS by 13c
Tweet
Share
E-mailGet Alerts FMTX Hot Sheet
Join SI Premium – FREE
Forma Therapeutics Holdings (NASDAQ: FMTX) reported Q2 EPS of ($0.92), $0.13 worse than the analyst estimate of ($0.79).
For earnings history and earnings-related data on Forma Therapeutics Holdings (FMTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla to launch Cybercab in Austin this month - report
- DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
- RBC Capital Downgrades Hermes International (RMS:FP) (HESAY) to Sector Perform
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
